Please donate here to support this vital work.
Revealing News For a Better World

Mind-Altering Drugs News Articles
Excerpts of key news articles on mind-altering drugs


Below are key excerpts of little-known, yet highly revealing news articles on mind-altering drugs from the major media. Links are provided to the full articles for verification. If any link fails to function, read this webpage. These mind-altering drugs news articles are listed by order of importance. You can also explore them listed by order of the date of the article or by the date posted. By choosing to educate ourselves, we can and will build a brighter future.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.


How LSD Makes Your Brain One With The Universe
2016-04-13, NPR
http://www.npr.org/sections/health-shots/2016/04/13/474071268/how-lsd-makes-y...

Some users of LSD say one of the most profound parts of the experience is a deep oneness with the universe. The sensation ... correlates to changes in brain connectivity while on LSD, according to a study published Wednesday in Current Biology. An MRI scanner [showed that] the brains of people on acid looked markedly different than those on the placebo. Their sensory cortices, which process sensations like sight and touch, became far more connected than usual to the frontal parietal network, which is involved with our sense of self. "The stronger that communication, the stronger the experience of the dissolution (of self)," says Enzo Tagliazucchi, the [study's] lead author. Researchers also measured the volunteers' brain electrical activity with another device. Our brains normally generate a regular rhythm of electrical activity called the alpha rhythm, which links to our brain's ability to suppress irrelevant activity. But in a different paper published on Monday in the Proceedings of the National Academy of Sciences, he and several co-authors show that LSD weakens the alpha rhythm. He thinks this weakening could make the hallucinations seem more real. The idea is intriguing ... says Dr. Charles Grob, a psychiatrist at the Harbor-UCLA Medical Center. "They may genuinely be on to something. This should really further our understanding of the brain and consciousness." And, he says, the work highlights hallucinogens' powerful therapeutic potential.

Note: While the war on drugs has been called a "trillion dollar failure", studies like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


LSD's impact on the brain revealed in groundbreaking images
2016-04-11, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/science/2016/apr/11/lsd-impact-brain-revealed-gro...

The profound impact of LSD on the brain has been laid bare by the first modern scans of people high on the drug. The images, taken from volunteers ... revealed that trippers experienced images through information drawn from many parts of their brains. Under the drug, regions once segregated spoke to one another. Further images showed that other brain regions that usually form a network became more separated in a change that accompanied users’ feelings of oneness with the world, a loss of personal identity called “ego dissolution”. David Nutt, the government’s former drugs advisor ... and senior researcher on the study, said, “This is to neuroscience what the Higgs boson was to particle physics.” [Study co-author Robin] Carhart-Harris said, “We saw many more areas of the brain than normal were contributing to visual processing under LSD, even though volunteers’ eyes were closed.” The more prominent the effect, the more intense people rated their dreamlike visions. Under the influence, brain networks that deal with vision, attention, movement and hearing became far more connected. But at the same time, other networks broke down. The drug can be seen as reversing the more restricted thinking we develop from infancy to adulthood. The study could pave the way for LSD or related chemicals to be used to treat psychiatric disorders. Nutt said the drug could pull the brain out of thought patterns seen in depression and addiction through its effects on brain networks.

Note: For more, see an NPR article titled "How LSD Makes Your Brain One With The Universe". This ground-breaking study appears in the journal Proceedings of the National Academy of Sciences. While the war on drugs has been called a "trillion dollar failure", studies like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


LSD could make you smarter, happier and healthier.
2016-04-01, Washington Post
https://www.washingtonpost.com/posteverything/wp/2016/04/01/lsd-could-make-yo...

In 1970, Congress dropped psychedelics into the war on drugs. The federal government declared that the drugs had no medical use - and high potential for abuse. Over the past decade, some scientists have begun to challenge that conclusion. Far from being harmful, they found, hallucinogens can help sick people: They helped alcoholics drink less; terminal patients eased more gently into death. And it’s not just the infirm who are helped by the drugs. They can help us solve problems more creatively and make us more open-minded and generous. Scientists think [that] when someone takes a psychedelic, there is a decrease in blood flow and electrical activity in the brain’s “default mode network,” [which] is primarily responsible for our ego or sense of self. When we trip, our default mode network slows down. With the ego out of commission, the boundaries between self and world, subject and object dissolve. Robin Carhart-Harris, a neuroscientist with Imperial College London, notes that the default mode network is responsible for a lot of our rigid, habitual thinking and obsessions. Psychedelics help relax the part of the brain that leads us to obsess. And they can help “loosen if not break” the entrenched physical circuits responsible for addictive behavior. Steve Jobs famously said that taking LSD “was one of the most important things in my life.” The entrepreneur Tim Ferriss said that “the billionaires I know, almost without exception, use hallucinogens on a regular basis.”

Note: While the war on drugs has been called a "trillion dollar failure", articles like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


Mind-Altering Drugs Could Cure PTSD
2015-12-22, Popular Science
http://www.popsci.com/mind-altering-drugs-can-cure-ptsd

About 8 percent of Americans experience PTSD; for veterans, that number is 30 percent. Treatment is notoriously difficult, but people could find relief in an unusual form: psychedelic drugs. MDMA - found in molly and ecstasy - earned a bad rap in the 1990s as ravers’ drug of choice. But psychotherapists are coming to value the way it increases empathy while decreasing fear and defensiveness. “MDMA gives people the ability to revisit an event that’s still painful without being overwhelmed,” says psychiatrist Michael Mithoefer. Following a recent MDMA trial, 83 percent of his treatment-resistant participants no longer showed symptoms of PTSD. In one study, Mithoefer worked with a New York City firefighter post-9/11. The subject had tried treatment before. While undergoing a popular method that uses eye movement to reprocess a trauma, he’d been so overcome that he ripped a sink off the wall. MDMA, however, worked. “It wasn’t easy for him,” Mithoefer says. “But our sink is still attached.” MDMA isn’t a one-trick pony either; it can treat end-of-life anxiety and alcoholism, and it’s not addictive. “We’re talking about the rise of a whole field of medicine,” says Rick Doblin, founder of the nonprofit Multidisciplinary Association for Psychedelic Studies, which is running a handful of MDMA trials, including Mithoefer’s. Doblin thinks the FDA will greenlight the drug for mainstream use by 2021.

Note: While the war on drugs has been called a "trillion dollar failure", the healing potentials of mind altering drugs are starting to be investigated more openly.


Psychedelic drugs may be ready for a medical comeback
2015-09-08, Los Angeles Times
http://www.latimes.com/science/sciencenow/la-sci-sn-psychedelic-drugs-medical...

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community, says a new analysis in the Canadian Medical Assn. Journal. For several decades, the North American medical establishment has classified psychedelic drugs – including LSD, psilocybin and [MDMA, better known as ecstasy] – as drugs of abuse with little to no medical purpose or means of safe use. That, four researchers argue, is changing. In Switzerland, Canada, Brazil, Peru, Mexico and the United States, researchers with no evident countercultural tendencies are conducting research that is finding psychedelic drugs a valuable adjunct to psychotherapy in treating addiction, post-traumatic stress and the depression or anxiety that often comes with terminal illness. Clinical investigators are demonstrating that such research "can conform to the rigorous scientific, ethical and safety standards expected of contemporary medical research," the authors write in the new analysis, titled "Psychedelic medicine: a re-emerging therapeutic paradigm." And the body of research they are generating is demonstrating that such drugs as MDMA, LSD and psilocybin can be effective in treating well-chosen patients. Two other factors - cost and time - also appear to be opening minds about the potential therapeutic uses of psychedelic drugs.

Note: For more about the therapeutic uses of psychedelic drugs, see these concise summaries of deeply revealing news articles from reliable sources.


Book review: ‘Acid Test,’ on psychedelic drug therapy for PTSD
2014-09-11, Washington Post
http://www.washingtonpost.com/opinions/book-review-acid-test-on-lsd-as-therap...

LSD, ecstasy (MDMA) and other psychedelics are powerful, mind-altering drugs that, as described by former Washington Post Magazine editor Tom Shroder, “intrinsically [challenge] the rationalist, materialist underpinnings of Western culture.” For most of a century, our society has struggled to come to grips with these “profoundly threatening drugs,” largely without success. They’ve all been made illegal. For decades, the Food and Drug Administration and the Drug Enforcement Administration have strictly banned scientific investigations into their potential benefits — which is unfortunate, since these psychoactive drugs also seem able to do incredible good, particularly in the treatment of post-traumatic stress disorder (PTSD). Every year, as many as 5 million Americans suffer from its effects. Frequent consequences include depression, drug and alcohol abuse, and a host of associated health problems. In “both humanitarian and economic terms,” the costs are staggering. And PTSD stubbornly resists treatment. Psychoactive drugs such as LSD and MDMA seem to bring powerful healing energies to bear on the underlying issues. But despite a growing mountain of evidence supporting the therapeutic benefits delivered by these drugs, government authorities have blocked scientific and therapeutic explorations of their potential. Fortunately, the government’s prohibitions may be loosening, thanks to a cadre of psychedelic advocates who have steadfastly refused to surrender to the taboos. The story of those people and their efforts to win scientific and therapeutic approval for psychedelic drugs is the central thrust of Shroder’s strangely wonderful new book, Acid Test: LSD, Ecstasy, and the Power to Heal.

Note: For more on this, see concise summaries of deeply revealing mind-altering drugs news articles from reliable major media sources.


A brief history of psychedelic psychiatry
2014-09-02, The Guardian (One of the UK's leading newspapers)
http://www.theguardian.com/science/neurophilosophy/2014/sep/02/psychedelic-ps...

On 5th May, 1953, the novelist Aldous Huxley dissolved four-tenths of a gram of mescaline in a glass of water, drank it, then sat back and waited for the drug to take effect. Huxley took the drug in his California home under the direct supervision of psychiatrist Humphry Osmond, to whom Huxley had volunteered himself as “a willing and eager guinea pig”. Osmond was one of a small group of psychiatrists who pioneered the use of LSD as a treatment for alcoholism and various mental disorders in the early 1950s. He coined the term psychedelic, meaning ‘mind manifesting’ and although his research into the therapeutic potential of LSD produced promising initial results, it was halted during the 1960s for social and political reasons. While at St. George’s [Hospital after WWII], Osmond and his colleague John Smythies learned about Albert Hoffman’s discovery of LSD at the Sandoz Pharmaceutical Company in Bazel, Switzerland. Osmond and Smythies started their own investigation into the properties of hallucinogens. Osmond tried LSD himself and concluded that the drug could produce profound changes in consciousness. Osmond and [Abram] Hoffer also recruited volunteers to take LSD and theorised that the drug was capable of inducing a new level of self-awareness which may have enormous therapeutic potential. In 1953, they began giving LSD to their patients, starting with some of those diagnosed with alcoholism. Their first study involved two alcoholic patients, each of whom was given a single 200-microgram dose of the drug. One of them stopped drinking immediately after the experiment. The other stopped 6 months later. Osmond and Hoffer were encouraged, and continued to administer the drug to alcoholics. Their studies seemed to show that a single, large dose of LSD could be an effective treatment for alcoholism, and reported that between 40 and 45% of their patients given the drug had not experienced a relapse after a year.

Note: For more on this, see concise summaries of deeply revealing mind-altering drugs news articles from reliable major media sources.


How did Alexander Shulgin become known as the Godfather of Ecstasy?
2014-06-03, The Guardian (One of the UK's leading newspapers)
http://www.theguardian.com/science/shortcuts/2014/jun/03/alexander-shulgin-ma...

The explosion of dance music culture during the late '80s and early '90s conferred fame on some unlikely people, but few were quite as unlikely as Alexander Shulgin, who died on 2 June at his home in California at the age of 88. He was nearly 70 by the time he became known as the Godfather of Ecstasy, a title that made it sound like he had invented MDMA, which he hadn't: Shulgin had only introduced the drug to west coast psychotherapists in the late 70s. But, he had created more than 200 psychoactive compounds in his home laboratory, tested them all on himself and his wife and written about them in a 1991 book titled Phenethylamines I Have Known and Loved. The combination of the book, his association with ecstasy, and that drug's burgeoning popularity made him a hugely celebrated figure. Shulgin thought all drugs should be legalised, but he seemed about as far removed from the bug-eyed psychedelic proselyte of popular myth as it was possible to get. His writing was measured, calm and witty. He did not court the attention of the rave generation. If anything, he seemed faintly exasperated by the way MDMA was being used. "Go banging about with a psychedelic drug for a Saturday night turn-on, and you can get into a really bad place, psychologically," he had warned. Later he was to lament that MDMA had been "sidetracked into the Yahoo generation". None of the drugs Shulgin invented became as famous as the one he didn't. In the late '90s, there was talk that a compound called 2CB was "the new ecstasy" but it never attained the ubiquity of E. Nevertheless, Shulgin's legend was assured.

Note: To see Shulgin's fun and iconoclastic character, watch this fun four-minute video. Explore major media articles showing breakthroughs in therapy from an excellent compilation of news articles on mind altering drugs. And read the personal journey to healing of courageous CNN reporter Amber Lyon using these "medicines."


A ‘Party Drug’ May Help the Brain Cope With Trauma
2012-11-20, New York Times
http://www.nytimes.com/2012/11/20/health/ecstasy-treatment-for-post-traumatic...

Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it. The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and ’90s that can induce pulses of euphoria and a radiating affection. Government regulators criminalized the drug in 1985, placing it on a list of prohibited substances that includes heroin and LSD. But in recent years, regulators have licensed a small number of labs to produce MDMA for research purposes. In a paper posted online ... by the Journal of Psychopharmacology, Michael and Ann Mithoefer, the husband-and-wife team offering the treatment — which combines psychotherapy with a dose of MDMA — write that they found 15 of 21 people who recovered from severe post-traumatic stress in the therapy in the early 2000s reported minor to virtually no symptoms today. The Mithoefers — he is a psychiatrist and she is a nurse — collaborated on the study with researchers at the Medical University of South Carolina and the nonprofit Multidisciplinary Association for Psychedelic Studies. The patients in this group included mostly rape victims, and experts familiar with the work cautioned that it was preliminary, based on small numbers, and its applicability to war trauma entirely unknown.

Note: For the paper on this remarkable study published published online in the Journal of Psychopharmacology, click here. For deeply revealing reports from reliable major media sources on beneficial mind-altering drugs, click here.


Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find
2012-09-06, The Daily Beast/Newsweek
http://www.thedailybeast.com/articles/2012/09/06/marijuana-fights-cancer-and-...

Mounting evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Peer-reviewed studies in several countries ... show that THC and other marijuana-derived compounds, known as “cannabinoids,” are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. THC treatment was associated with significantly reduced tumor cell proliferation in every test subject. Harvard University scientists reported that THC slows tumor growth in common lung cancer and “significantly reduces the ability of the cancer to spread.” What’s more ... THC selectively targets and destroys tumor cells while leaving healthy cells unscathed. Conventional chemotherapy drugs, by contrast, are highly toxic; they indiscriminately damage the brain and body. There is mounting evidence ... that cannabinoids “represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells.” Within the medical science community, the discovery that cannabinoids have anti-tumoral properties is increasingly recognized as a seminal advancement in cancer therapeutics.

Note: Yet treatment with cannabinoids continues to be largely illegal in the US. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply revealing reports from reliable major media sources on promising cancer-cure research, click here.


Can a hallucinogen from Africa cure addiction?
2012-04-13, BBC News
http://www.bbc.co.uk/news/magazine-17666589

Since the 1960s a disparate group of scientists and former drug addicts have been advocating a radical treatment for addiction - a hallucinogen called ibogaine, derived from an African plant, that in some cases seems to obliterate withdrawal symptoms from heroin, cocaine and alcohol. So why isn't it widely used? The drug, derived from the root of a central African plant called iboga, had been used for centuries by the Bwiti people of Gabon and Cameroon, as part of a tribal initiation ceremony. But it wasn't until 1962, when a young heroin addict called Howard Lotsof stumbled upon ibogaine, that its value as an addiction treatment was uncovered. Lotsof took it to get high but when the hallucinogenic effects wore off, he realised he no longer had the compulsion to take heroin. He became convinced that he had found the solution to addiction and dedicated much of his life to promoting ibogaine as a treatment. Ibogaine affects the brain in two distinct ways. The first is metabolic. It creates a protein that blocks receptors in the brain that trigger cravings, stopping the symptoms of withdrawal. With normal detox this process can take months. Its second effect is much less understood. It seems to inspire a dream-like state that is intensely introspective, allowing addicts to address issues in their life that they use alcohol or drugs to suppress.

Note: For more news articles from reliable sources on mind-altering drugs, click here.


Learning from a '50s Housewife on Acid
2011-01-18, ABC News
http://abcnews.go.com/Health/1950s-housewife-acid/story?id=12640926

A video [that went viral] featured footage of a mid-1950s housewife on an acid trip during an LSD experiment. In the film, a researcher, Dr. Sidney Cohen, is shown interviewing, and then dosing, a volunteer at the Veteran's Administration Hospital in Los Angeles. The woman, who is identified only as the wife of a hospital employee, is in her late 20s or early 30s and appears fairly typical of her time. LSD was a legal pharmaceutical drug until 1966. Journalist Don Lattin says he came across the video in the archives of philosopher Gerald Heard while researching a group biography on him, the British writer Aldous Huxley, and Bill Wilson, co-founder of Alcoholics Anonymous. In the video that Lattin posted online, [the housewife] is clearly under the influence and appears to be rather enjoying it. She says: "Everything is alive. This is reality. I wish you could see it. I wish I could talk in technicolor." "This shows that very early on in the 1950s, researchers were aware that there were possible beneficial uses, rather than military or more nefarious uses," he says. In the early 1950s and into the '60s the Army and CIA secretly funded a lot of research to see if LSD could be used as a chemical weapon or a truth serum, says Lattin. But Cohen and his ilk were pursuing a different line of study. They wanted to understand how it works, how the mind works and the connection between the psychotic state and a spiritually enlightened state." Indeed, Wilson, the AA co-founder, did a fair amount of LSD in the 50s , says Lattin. "This surprises people, but he wasn't doing it to get high," he adds. "It was to achieve that spiritual awakening."

Note: The video of this session is quite inspiring. See it at this link. For more on mind-altering drugs, see the deeply revealing reports from reliable major media sources available here.


Pont-Saint-Esprit poisoning: Did the CIA spread LSD?
2010-08-23, BBC News
http://www.bbc.co.uk/news/world-10996838

Nearly 60 years ago, a French town was hit by a sudden outbreak of hallucinations, which left five people dead and many seriously ill. On 16 August 1951, postman Leon Armunier was doing his rounds in the southern French town of Pont-Saint-Esprit when he was suddenly overwhelmed by nausea and wild hallucinations. "It was terrible. I had the sensation of shrinking and shrinking, and the fire and the serpents coiling around my arms," he remembers. Leon, now 87, fell off his bike and was taken to the hospital in Avignon. Over the coming days, dozens of other people in the town fell prey to similar symptoms. Doctors at the time concluded that bread at one of the town's bakeries had become contaminated by ergot, a poisonous fungus that occurs naturally on rye. That view remained largely unchallenged until 2009, when an American investigative journalist, Hank Albarelli, revealed a CIA document labelled: "Re: Pont-Saint-Esprit and F.Olson Files. SO Span/France Operation file, inclusive Olson. Intel files. Hand carry to Belin - tell him to see to it that these are buried." F. Olson is Frank Olson, a CIA scientist who, at the time of the Pont St Esprit incident, led research for the agency into the drug LSD. David Belin, meanwhile, was executive director of the Rockefeller Commission created by the White House in 1975 to investigate abuses carried out worldwide by the CIA. Albarelli believes the Pont-Saint-Esprit and F. Olson Files, mentioned in the document, would show - if they had not been "buried" - that the CIA was experimenting on the townspeople, by dosing them with LSD.

Note: Frank Olson later had his drink spiked with LSD and allegedly committed suicide shortly thereafter. Yet many believe he was "suicided" as he was having misgivings about his involvement in this program and considering spilling the beans, as reported in this news article. For an overview of CIA mind-control experimentation, click here.


F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients
2016-11-29, New York Times
http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html?_r=0

After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world. He had tried almost all the accepted treatments for post-traumatic stress disorder. “Nothing worked for me,” said Mr. Hardin. Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the illegal party drug better known as Ecstasy. “It changed my life,” he said. “It allowed me to see my trauma without fear or hesitation and finally process things and move forward.” Based on promising results like Mr. Hardin’s, the Food and Drug Administration gave permission Tuesday for large-scale, Phase 3 clinical trials of the drug - a final step before the possible approval of Ecstasy as a prescription drug. The Multidisciplinary Association for Psychedelic Studies, a small nonprofit created in 1985 ... sponsored six Phase 2 studies treating a total of 130 PTSD patients. Two trials ... focused on treating combat veterans, sexual assault victims, and police and firefighters with PTSD who had not responded to traditional prescription drugs or psychotherapy. Patients had, on average, struggled with symptoms for 17 years. After three doses of MDMA administered under a psychiatrist’s guidance, the patients reported a 56 percent decrease of severity of symptoms on average, one study found. By the end of the study, two-thirds no longer met the criteria for having PTSD. Follow-up examinations found that improvements lasted more than a year after therapy.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. This FDA approval to begin Phase 3 clinical trials of MDMA suggests that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


‘It can rewire people’s brains’: how traumatised veterans turned to underground MDMA therapy
2018-11-17, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/film/2018/nov/18/it-can-rewire-peoples-brains-how...

Dead Dog on the Left isn’t just a documentary about the use of ecstasy in treating PTSD, it’s a story of the lengths one former marine will go to for friendship. [Tyler] McCourry and [Nigel] Flanigan are the subjects of [the] mini-documentary taken from a forthcoming feature film, MDMA the Movie, which explores the history of the so-called “party drug” more popularly known as ecstasy, its use in therapy, and harm reduction. Both films are directed by Emanuel Sferios. His protagonists may have survived the Iraq war, but only barely. Suicidal thoughts have stalked them both. In May 2012 McCourry did his first [MDMA-assisted psychotherapy] session ... lying in bed, flanked by two therapists. At the beginning of the session he was given a 75mg dose of MDMA. “During those eight hours you’re addressing the most challenging situations in your life,” he says. “It feels very exhausting, like it was some of the most work you’ve ever done in one day.” McCourry calls those trials, now completed, “a transformation of the psyche”. MDMA-assisted psychotherapy has “breakthrough therapy” designation by the FDA. “Since the MDMA therapy I’m able to recognise when something comes up that I need to talk about,” [McCourry] says. McCourry hopes that the therapy will be adopted by the Veterans Administration and Department of Defense. “If you can cure PTSD after three sessions of MDMA therapy then you don’t have to provide a veteran with medications for the rest of their life and talk therapy once a month.”

Note: A touching 26-documentary on this case is available at the above link. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Investors are starting to bet big on psychedelic medicine
2019-03-23, CNBC News
https://www.cnbc.com/2019/03/27/psychedelic-medicine-start-ups-vet-ketamine-p...

Psychedelic medicine is having a moment. Just weeks after the U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-like nasal spray for depression, a group of European technology investors ... got together for the largest-ever private financing round for a psychedelic medicine biotech company, ATAI. Psychedelic medicine involves research and investigations into mind-altering substances to treat mental illnesses including addiction, depression and post-traumatic stress disorder. After recreational use of psychedelics became popular in the 1960s, the U.S. government classified most of them “drugs of abuse” with no real medical value. However, recent clinical studies show mounting evidence that some psychedelics can help patients with certain mental illnesses, either in combination with traditional therapies or in cases where nothing else has worked. Now health and technology investors are paying attention. German company ATAI Life Sciences announced on Tuesday that it has raised more than $40 million in new financing. The round valued the company at $240 million, according to a person familiar, making it both the biggest round and the most valuable company in the young space. ATAI is currently funding clinical trials for what it refers to as “formerly stigmatized compounds,” including psilocybin, the active compound in psychedelic mushrooms, and arketamine, a different variant of ketamine from the one Johnson & Johnson researched, as potential treatments for depression.

Note: Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Study: Patients Find More Relief In Marijuana's Psychoactive Compound THC Than In CBD
2019-02-27, Forbes
https://www.forbes.com/sites/javierhasse/2019/02/27/study-patients-find-more-...

CBD, the non-psychoactive compound found in cannabis, hemp and hops, has been getting a lot of attention from the media recently. On the other hand, THC, the psychoactive compound in cannabis that makes people feel “high” or “stoned,” is often overlooked (and sometimes even looked down on) when discussing marijuana’s medical potential. However, a new study ... published on the Scientific Reports journal on Tuesday, revealed that THC exhibited the “strongest correlation with therapeutic relief, compared to the more socially acceptable chemical found in cannabis, CBD (cannabinol).” Cannabinoid content, and especially THC content, came out as the main factor for optimizing symptom relief, when tested for a wide variety of health conditions. [Study co-author Jacob Miguel] Vigil explained the results derived from the observation of real-time data from Releaf App, which he qualified as “the largest database of its kind in our country.” Using the app, patients reported the results and effects of their actual cannabis use. The researchers discovered cannabis is more effective for the treatment of mental symptoms like agitation, irritability, anxiety, depression, excessive appetite, insomnia, loss of appetite, nausea, gastrointestinal pain, stress and tremors, than it is in the treatment of physical ailments. Despite the conventional wisdom ... that only CBD has medical benefits while THC merely makes one high, our results suggest that THC may be more important than CBD in generating therapeutic benefits.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and the healing potentials of mind-altering drugs.


MDMA to be Used in Trauma Treatment in Israel and U.S. May Not be Far Behind
2019-02-11, Newsweek
https://www.newsweek.com/mdma-be-used-trauma-treatment-israel-and-us-may-not-...

MDMA, the principal ingredient in the party drug ecstasy, is about to give a lifeline to some of the worst sufferers of post-traumatic stress disorder (PTSD) in Israel. The U.S. could be just years behind in launching similar clinical treatments using the substance. Israel’s Ministry of Health has approved the use of MDMA, a psychoactive drug, for use on dozens of patients. While the drug is still on the country’s law books as dangerous for recreational use, it is now being administered as treatment for compassionate use. In compassionate cases the drug will be made available to patients outside of clinical trials if they have not responded sufficiently to other medications or treatments. MDMA makes people feel euphoric, a sensation that made its use synonymous with rave culture and EDM (Electronic Dance Music), because it floods the body with serotonin. Serotonin is produced by nerve cells. When levels are low it can lead to depression and disrupt other physiological processes. The launching of the new Israeli initiative is a direct result of groundbreaking research in the U.S. The Middle Eastern nation approved the program after sending a representative to the California-based Multidisciplinary Association for Psychedelic Studies (MAPS) for training. MDMA has been illegal in the U.S. since 1985 but the findings of clinical trials, ongoing with Food and Drug Administration (FDA) approval since 2001, have shown that the drug enhances the treatment of PTSD in a clinical setting.

Note: Read also a CBC article titled "How psychedelic drugs are changing lives and transforming psychiatry." For more along these lines, see concise summaries of deeply revealing mind altering drugs news articles from reliable major media sources.


MDMA, the main ingredient in ecstasy, could be key in helping veterans with PTSD
2018-09-18,
https://www.cbsnews.com/news/mdma-the-main-ingredient-in-ecstasy-could-be-key...

It's the little things that Jon Lubecky appreciates now, like playing a board game with his family. But it wasn't always that way for the former Army sniper, who came home in 2006 after nearly a year in Iraq with a traumatic brain injury from a mortar attack and a nasty case of post-traumatic stress disorder (PTSD). Traditional treatments, including the use of antidepressants like Zoloft, were useless. Over three sessions, Lubecky spent six to eight hours under the influence of MDMA, the active ingredient in ecstasy. Finally, Lubecky was able to talk about his trauma and thus make progress dealing with it. Rick Doblin runs the Multidisciplinary Association for Psychedelic Studies, or MAPS, a non-profit advocating for MDMA-assisted psychotherapy. "It starts by reducing activity in the amygdala, which is the fear-processing part of the brain, so that people's fearful emotions linked to trauma can be more easily recalled and processed," Doblin said. Once the drug produces feelings of safety, veterans can then access memories which had been crippling before. While one in three veterans found pills like Zoloft and Paxil effective in treating their PTSD, a study including 24 veterans showed PTSD was eliminated in 68 percent of vets treated with MDMA-assisted therapy and significantly reduced in the other 32 percent. MDMA-assisted therapy is now about to begin its third phase of FDA testing. If all goes well, MDMA will be available by prescription as early as 2021.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs.


Canada becomes second nation in the world to legalize marijuana
2018-06-20, CNN News
https://www.cnn.com/2018/06/20/health/canada-legalizes-marijuana/index.html

Recreational marijuana use will soon be legal in Canada after the Senate passed a "historic" bill. Canada is only the second country in the world - and the first G7 nation - to implement legislation to permit a nationwide marijuana market. In the neighboring US, nine states and the District of Columbia now allow for recreational marijuana use, and 30 allow for medical use. The Cannabis Act, stems from a campaign pledge of Prime Minister Justin Trudeau to keep marijuana away from underage users and reduce related crime. Uruguay was the first country to legalize marijuana's production, sale and consumption in December 2013. The justice minister, Jody Wilson-Raybould, ... applauded the vote. "This is an historic milestone for progressive policy in Canada," she tweeted. "This legislation will help protect our youth from the risks of cannabis while keeping profits out of the hands of criminals and organized crime." Once the bill is formally approved, adults will be able to carry and share up to 30 grams of legal marijuana in public. They also will be allowed to cultivate up to four plants in their households. However, stringent rules will still govern the purchase and use of marijuana. Consumers are expected to purchase marijuana from [regulated] retailers. Marijuana will also not be sold in the same location as alcohol or tobacco. The Canadian government has also implemented changes to their impaired driving laws, to address repercussions for driving under the influence of cannabis.

Note: In the US, more people are arrested for marijuana use than for all violent crimes combined.


Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Kindly donate here to support this inspiring work.

Subscribe to our free email list of underreported news.

newsarticles.media is a PEERS empowerment website

"Dedicated to the greatest good of all who share our beautiful world"